Rankings
▼
Calendar
VCEL FY 2025 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$276M
+16.5% YoY
Gross Profit
$206M
74.4% margin
Operating Income
$11M
4.0% margin
Net Income
$17M
6.0% margin
EPS (Diluted)
$0.32
Cash Flow
Operating Cash Flow
$52M
Free Cash Flow
$25M
Stock-Based Comp.
$39M
Balance Sheet
Total Assets
$488M
Total Liabilities
$133M
Stockholders' Equity
$355M
Cash & Equivalents
$100M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$276M
$237M
+16.5%
Gross Profit
$206M
$172M
+19.5%
Operating Income
$11M
$5M
+144.4%
Net Income
$17M
$10M
+59.4%
← Q4 2024
All Quarters
Q1 2025 →